Free tool
FAERS Monitor: Rytary
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203312 or its brand name (Rytary, Carbidopa, Levodopa). Reports on generic versions are filed under their own applications.
Reports
21,049
Serious
8,549
41% of reports
Hospitalization
3,866
Death reported
2,347
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective2,301
- tremor2,054
- hallucination1,815
- fall1,747
- dyskinesia1,614
- dizziness1,387
- nausea1,255
- death1,087
- parkinson^s disease1,000
- somnolence968
- fatigue932
- gait disturbance897
- confusional state836
- asthenia792
- therapeutic response shortened758
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 96 |
| 2005 | 92 |
| 2006 | 85 |
| 2007 | 107 |
| 2008 | 224 |
| 2009 | 122 |
| 2010 | 150 |
| 2011 | 141 |
| 2012 | 134 |
| 2013 | 31 |
| 2014 | 67 |
| 2015 | 322 |
| 2016 | 589 |
| 2017 | 2,115 |
| 2018 | 1,669 |
| 2019 | 2,686 |
| 2020 | 2,616 |
| 2021 | 2,415 |
| 2022 | 2,107 |
| 2023 | 1,515 |
| 2024 | 1,464 |
| 2025 | 1,437 |
| 2026 | 865 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,110 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyskinesiaSignal | 1,614 | 41.3 | 39.4 | 61,002 |
| hallucinationSignal | 1,815 | 24.6 | 23.6 | 40,283 |
| therapeutic response shortenedSignal | 758 | 23.3 | 21.8 | 15,848 |
| tremorSignal | 2,054 | 12.5 | 12.0 | 21,639 |
| fallSignal | 1,747 | 5.3 | 5.0 | 6,101 |
| confusional stateSignal | 836 | 5.2 | 4.9 | 2,832 |
| somnolenceSignal | 968 | 4.8 | 4.5 | 2,943 |
| gait disturbanceSignal | 897 | 4.7 | 4.4 | 2,621 |
| dizzinessSignal | 1,387 | 2.8 | 2.6 | 1,617 |
| astheniaSignal | 792 | 2.1 | 2.0 | 467 |
| drug ineffective | 2,301 | 1.7 | 1.7 | 780 |
| nausea | 1,255 | 1.6 | 1.5 | 281 |
| death | 1,087 | 1.3 | 1.2 | 61 |
| fatigue | 932 | 1.2 | 1.1 | 31 |
| parkinson^s disease | 1,000 | 0.0 | 0.0 | 998,293 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.